Morgan Stanley analyst Thibault Boutherin raised the firm’s price target on Sandoz (SDZNY) to CHF 41 from CHF 35 and keeps an Equal Weight rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SDZNY:
- Sandoz downgraded to Neutral from Buy at UBS
- Sandoz price target raised to CHF 41 from CHF 39 at Berenberg
- FDA adds boxed warning to Teva’s Copaxone for allergic reaction
- M&A News: Intra-Cellular Stock Rallies 36% on News of $14.6B Acquisition by Johnson & Johnson
- Intra-Cellular price target raised to $118 from $100 at BofA